Correlation Between Pfizer and Dupont Denemours

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Dupont Denemours at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Dupont Denemours into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Dupont Denemours, you can compare the effects of market volatilities on Pfizer and Dupont Denemours and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Dupont Denemours. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Dupont Denemours.

Diversification Opportunities for Pfizer and Dupont Denemours

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Pfizer and Dupont is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Dupont Denemours in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dupont Denemours and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Dupont Denemours. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dupont Denemours has no effect on the direction of Pfizer i.e., Pfizer and Dupont Denemours go up and down completely randomly.

Pair Corralation between Pfizer and Dupont Denemours

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Dupont Denemours. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.42 times less risky than Dupont Denemours. The stock trades about -0.18 of its potential returns per unit of risk. The Dupont Denemours is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest  5,558  in Dupont Denemours on June 30, 2022 and sell it today you would lose (549.00)  from holding Dupont Denemours or give up 9.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Dupont Denemours

 Performance (%) 
       Timeline  
Pfizer Inc 
Pfizer Performance
0 of 100
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in October 2022. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pfizer Price Channel

Dupont Denemours 
Dupont Performance
0 of 100
Over the last 90 days Dupont Denemours has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Dupont Price Channel

Pfizer and Dupont Denemours Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Dupont Denemours

The main advantage of trading using opposite Pfizer and Dupont Denemours positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Dupont Denemours can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dupont Denemours will offset losses from the drop in Dupont Denemours' long position.
Pfizer vs. Kibush Capital Corp
The idea behind Pfizer Inc and Dupont Denemours pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Dupont Denemours vs. Kibush Capital Corp
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go